Provided by Tiger Trade Technology Pte. Ltd.

Krystal Biotech Inc.

266.90
-7.6900-2.80%
Post-market: 266.900.00000.00%19:51 EST
Volume:351.01K
Turnover:93.73M
Market Cap:7.74B
PE:39.02
High:275.00
Open:274.59
Low:262.33
Close:274.59
52wk High:298.30
52wk Low:122.80
Shares:29.00M
Float Shares:22.98M
Volume Ratio:0.69
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.84
EPS(LYR):6.84
ROE:18.91%
ROA:8.44%
PB:6.35
PE(LYR):39.02

Loading ...

Krystal Biotech RMAT Win Shifts Focus To Broader Gene Therapy Pipeline

Simply Wall St.
·
6 hours ago

Krystal Biotech Director Dino A. Rossi Disposes of Common Shares

Reuters
·
Yesterday

Stock Track | Krystal Biotech Soars 5.06% Intraday on FDA's RMAT Designation for KB707 Lung Cancer Therapy

Stock Track
·
Yesterday

RMAT Status Puts Krystal Biotech’s KB707 Oncology Ambitions In Focus

Simply Wall St.
·
Feb 23

Krystal Biotech Inc : Chardan Capital Markets Raises Target Price to $323 From $220

THOMSON REUTERS
·
Feb 18

Krystal Biotech Inc : Citigroup Raises Target Price to $371 From $336

THOMSON REUTERS
·
Feb 18

Stock Track | Krystal Biotech Soars 5.99% Intraday on Strong Q4 Earnings Beat

Stock Track
·
Feb 17

Earnings Flash (KRYS) Krystal Biotech Posts Q4 EPS $1.70, vs. FactSet Est of $1.54

MT Newswires Live
·
Feb 17

Krystal Biotech Q4 VYJUVEK revenue rises to USD 107.1 million, up 74% year-on-year

Reuters
·
Feb 17

BRIEF-Krystal Biotech Q4 Net Income USD 51.4 Million

Reuters
·
Feb 17

Krystal Biotech: Q4 EPS $1.70

THOMSON REUTERS
·
Feb 17

Assessing Krystal Biotech (KRYS) Valuation After KB707 RMAT Designation Boosts Oncology Pipeline Prospects

Simply Wall St.
·
Feb 14

Netflix Is Casting a Light on a Rare Disease. Pearl Jam's Frontman Is Raising Cash to Cure It. -- Barrons.com

Dow Jones
·
Feb 14

Krystal Biotech Chief Accounting Officer Kathryn Romano Reports Disposal of Common Shares

Reuters
·
Feb 12

Krystal Biotech Inc. to report financial results and host business update call

Reuters
·
Feb 10

Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS) and Palvella Therapeutics (PVLA)

TIPRANKS
·
Feb 10

FDA Grants RMAT Designation to Krystal Biotech's KB707 for Advanced NSCLC

Reuters
·
Feb 09

Krystal Biotech Announces Rmat Designation Granted by FDA to KB707 for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Feb 09

February 2026's Highlighted Stocks Estimated Below Intrinsic Value

Simply Wall St.
·
Feb 04

US High Growth Tech Stocks To Watch For Potential Gains

Simply Wall St.
·
Jan 28